{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:27:33Z","timestamp":1767338853684},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,10]]},"DOI":"10.7759\/cureus.24897","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T05:39:37Z","timestamp":1652247577000},"source":"Crossref","is-referenced-by-count":2,"title":["Randomized Clinical Trial on the Efficacy of Triple Therapy Versus Sequential Therapy in Helicobacter pylori Eradication"],"prefix":"10.7759","author":[{"given":"Zain","family":"Sharif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muaz","family":"Mubashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Atique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saira","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneeb","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Prevalence of Helicobacter pylori infection in children, a population-based cross-sectional study in West Iran","volume":"23","author":"Soltani J","year":"2013","unstructured":"Soltani J, Amirzadeh J, Nahedi S, Shahsavari S. Prevalence of Helicobacter pylori infection in children, a population-based cross-sectional study in West Iran. Iran J Pediatr. 2013, 23:13-8.","journal-title":"Iran J Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9463710","article-title":"Helicobacter pylori infection and its risk factors: a prospective cross-sectional study in resource-limited settings of northwest Ethiopia","volume":"2018","author":"Negash M","year":"2018","unstructured":"Negash M, Wondifraw Baynes H, Geremew D. Helicobacter pylori infection and its risk factors: a prospective cross-sectional study in resource-limited settings of northwest Ethiopia. Can J Infect Dis Med Microbiol. 2018, 2018:9463710. 10.1155\/2018\/9463710","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.19082\/7279","article-title":"Prevalence and factors associated with H. pylori infection in Saudi patients with dyspepsia","volume":"10","author":"Akeel M","year":"2018","unstructured":"Akeel M, Elmakki E, Shehata A, Elhafey A, Aboshouk T, Ageely H, Mahfouz MS. Prevalence and factors associated with H. pylori infection in Saudi patients with dyspepsia. Electron Physician. 2018, 10:7279-86. 10.19082\/7279","journal-title":"Electron Physician"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i32.4629","article-title":"Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing","volume":"25","author":"Pohl D","year":"2019","unstructured":"Pohl D, Keller PM, Bordier V, Wagner K. Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing. World J Gastroenterol. 2019, 25:4629-60. 10.3748\/wjg.v25.i32.4629","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_398_19","article-title":"Prevalence and patient characteristics of Helicobacter pylori among adult in primary health care of security forces hospital Riyadh, Saudi Arabia, 2018","volume":"8","author":"Alharbi RH","year":"2019","unstructured":"Alharbi RH, Ghoraba M. Prevalence and patient characteristics of Helicobacter pylori among adult in primary health care of security forces hospital Riyadh, Saudi Arabia, 2018. J Family Med Prim Care. 2019, 8:2202-6. 10.4103\/jfmpc.jfmpc_398_19","journal-title":"J Family Med Prim Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v4.i1.5","article-title":"Treatment of Helicobacter pylori infection: current and future insights","volume":"4","author":"Safavi M","year":"2016","unstructured":"Safavi M, Sabourian R, Foroumadi A. Treatment of Helicobacter pylori infection: current and future insights. World J Clin Cases. 2016, 4:5-19. 10.12998\/wjcc.v4.i1.5","journal-title":"World J Clin Cases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2015.30.8.1001","article-title":"Treatment of Helicobacter pylori infection in Korea: a systematic review and meta-analysis","volume":"30","author":"Lee SW","year":"2015","unstructured":"Lee SW, Kim HJ, Kim JG. Treatment of Helicobacter pylori infection in Korea: a systematic review and meta-analysis. J Korean Med Sci. 2015, 30:1001-9. 10.3346\/jkms.2015.30.8.1001","journal-title":"J Korean Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/diseases9040066","article-title":"Overview of Helicobacter pylori infection: clinical features, treatment, and nutritional aspects","volume":"9","author":"\u00d6ztekin M","year":"2021","unstructured":"\u00d6ztekin M, Y\u0131lmaz B, A\u011fag\u00fcnd\u00fcz D, Capasso R. Overview of Helicobacter pylori infection: clinical features, treatment, and nutritional aspects. Diseases. 2021, 9:10.3390\/diseases9040066","journal-title":"Diseases"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5009\/gnl20288","article-title":"Evidence-based guidelines for the treatment of Helicobacter pylori infection in Korea 2020","volume":"15","author":"Jung HK","year":"2021","unstructured":"Jung HK, Kang SJ, Lee YC, et al.. Evidence-based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. Gut Liver. 2021, 15:168-95. 10.5009\/gnl20288","journal-title":"Gut Liver"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-102967","article-title":"[S2k-guideline Helicobacter pylori and gastroduodenal ulcer  disease]","volume":"54","author":"Fischbach W","year":"2016","unstructured":"Fischbach W, Malfertheiner P, Lynen Jansen P, et al.. [S2k-guideline Helicobacter pylori and gastroduodenal ulcer  disease]. Z Gastroenterol. 2016, 54:327-63. 10.1055\/s-0042-102967","journal-title":"Z Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2018.17707","article-title":"Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: a prospective randomized study","volume":"29","author":"Ennkaa A","year":"2018","unstructured":"Ennkaa A, Shaath N, Salam A, Mohammad RM. Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: a prospective randomized study. Turk J Gastroenterol. 2018, 29:549-54. 10.5152\/tjg.2018.17707","journal-title":"Turk J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15171\/mejdd.2018.117","article-title":"Comparison of levofloxacin-based, 10-day sequential therapy with 14-day quadruple therapy for Helicobacter pylori eradication: a randomized clinical trial","volume":"10","author":"Hajiani E","year":"2018","unstructured":"Hajiani E, Alavinejad P, Avandi N, Masjedizadeh AR, Shayesteh AA. Comparison of levofloxacin-based, 10-day sequential therapy with 14-day quadruple therapy for Helicobacter pylori eradication: a randomized clinical trial. Middle East J Dig Dis. 2018, 10:242-8. 10.15171\/mejdd.2018.117","journal-title":"Middle East J Dig Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i18.5283","article-title":"Treatment of Helicobacter pylori infection: current status and future concepts","volume":"20","author":"Yang JC","year":"2014","unstructured":"Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: current status and future concepts. World J Gastroenterol. 2014, 20:5283-93. 10.3748\/wjg.v20.i18.5283","journal-title":"World J Gastroenterol"},{"key":"ref14","article-title":"Macrolide and fluoroquinolone resistance in Helicobacter pylori isolates: an experience at a tertiary care centre in Pakistan","volume":"62","author":"Rajper S","year":"2012","unstructured":"Rajper S, Khan E, Ahmad Z, Alam SM, Akbar A, Hasan R. Macrolide and fluoroquinolone resistance in Helicobacter pylori isolates: an experience at a tertiary care centre in Pakistan. J Pak Med Assoc. 2012, 62:1140-4.","journal-title":"J Pak Med Assoc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2021.02.128","article-title":"Concomitant therapy versus triple therapy: efficacy in H. pylori eradication and predictors of treatment failure","volume":"31","author":"Butt AM","year":"2021","unstructured":"Butt AM, Sarwar S, Nadeem MA. Concomitant therapy versus triple therapy: efficacy in H. pylori eradication and predictors of treatment failure. J Coll Physicians Surg Pak. 2021, 31:128-31. 10.29271\/jcpsp.2021.02.128","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref16","article-title":"Efficacy of standard triple therapy versus Levofloxacin based alternate therapy against Helicobacter pylori infection","volume":"68","author":"Latif S","year":"2018","unstructured":"Latif S, Akther N, Amjed S, et al.. Efficacy of standard triple therapy versus Levofloxacin based alternate therapy against Helicobacter pylori infection. J Pak Med Assoc. 2018, 68:1295-9.","journal-title":"J Pak Med Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5009\/gnl15470","article-title":"Sequential therapy versus triple therapy for the first line treatment of helicobacter pylori in Korea: a nationwide randomized trial","volume":"10","author":"Kim JS","year":"2016","unstructured":"Kim JS, Kim BW, Hong SJ, et al.. Sequential therapy versus triple therapy for the first line treatment of helicobacter pylori in Korea: a nationwide randomized trial. Gut Liver. 2016, 10:556-61. 10.5009\/gnl15470","journal-title":"Gut Liver"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14292","article-title":"Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication","volume":"33","author":"Auesomwang C","year":"2018","unstructured":"Auesomwang C, Maneerattanaporn M, Chey WD, Kiratisin P, Leelakusolwong S, Tanwandee T. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication. J Gastroenterol Hepatol. 2018, 33:1822-8. 10.1111\/jgh.14292","journal-title":"J Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2016.07.001","article-title":"Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment na\u00efve and retreat patients","volume":"17","author":"Abuhammour A","year":"2016","unstructured":"Abuhammour A, Dajani A, Nounou M, Zakaria M. Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment na\u00efve and retreat patients. Arab J Gastroenterol. 2016, 17:131-6. 10.1016\/j.ajg.2016.07.001","journal-title":"Arab J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4085-1","article-title":"Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study","volume":"19","author":"Jaka H","year":"2019","unstructured":"Jaka H, Mueller A, Kasang C, Mshana SE. Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study. BMC Infect Dis. 2019, 19:447. 10.1186\/s12879-019-4085-1","journal-title":"BMC Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2013.7.5.546","article-title":"Sequential therapy for Helicobacter pylori infection in Korea: systematic review and meta-analysis","volume":"7","author":"Kim JS","year":"2013","unstructured":"Kim JS, Kim BW, Ham JH, et al.. Sequential therapy for Helicobacter pylori infection in Korea: systematic review and meta-analysis. Gut Liver. 2013, 7:546-51. 10.5009\/gnl.2013.7.5.546","journal-title":"Gut Liver"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12034","article-title":"Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study","volume":"18","author":"Lim JH","year":"2013","unstructured":"Lim JH, Lee DH, Choi C, et al.. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Helicobacter. 2013, 18:180-6. 10.1111\/hel.12034","journal-title":"Helicobacter"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304820","article-title":"Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice","volume":"63","author":"McNicholl AG","year":"2014","unstructured":"McNicholl AG, Marin AC, Molina-Infante J, et al.. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. Gut. 2014, 63:244-9. 10.1136\/gutjnl-2013-304820","journal-title":"Gut"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5009\/gnl15091","article-title":"Mass eradication of Helicobacter pylori to prevent gastric cancer: theoretical and practical considerations","volume":"10","author":"Lee YC","year":"2016","unstructured":"Lee YC, Chiang TH, Liou JM, Chen HH, Wu MS, Graham DY. Mass eradication of Helicobacter pylori to prevent gastric cancer: theoretical and practical considerations. Gut Liver. 2016, 10:12-26. 10.5009\/gnl15091","journal-title":"Gut Liver"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i45.8188","article-title":"Stool antigen tests for the management of Helicobacter pylori infection","volume":"19","author":"Shimoyama T","year":"2013","unstructured":"Shimoyama T. Stool antigen tests for the management of Helicobacter pylori infection. World J Gastroenterol. 2013, 19:8188-91. 10.3748\/wjg.v19.i45.8188","journal-title":"World J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96510-randomized-clinical-trial-on-the-efficacy-of-triple-therapy-versus-sequential-therapy-in-helicobacter-pylori-eradication","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:15Z","timestamp":1707507315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96510-randomized-clinical-trial-on-the-efficacy-of-triple-therapy-versus-sequential-therapy-in-helicobacter-pylori-eradication"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.24897","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,10]]}}}